BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12624978)

  • 1. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
    Floch HA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
    Ishihara S; Hagiwara S; Fujuda T
    Microbios; 1977; 19(76):117-23. PubMed ID: 366337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 8. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine-resistant M. leprae.
    Levy L
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.
    Gelber RH; Rea TH; Murray LP; Siu P; Tsang M; Byrd SR
    Arch Dermatol; 1990 Dec; 126(12):1584-6. PubMed ID: 2256685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
    Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
    Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
    Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
    Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
    Sreevatsa ; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofazimine in the treatment of dapsone resistant leprosy.
    Taylor PM; Alexander R
    Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary and primary dapsone resistant leprosy: an analysis of 199 patients from St. Thomas Hospital and leprosy project, Chettupattu, South India.
    Aschhoff M; Raj PP; Lilly L; Srinivasan H
    Indian J Lepr; 1988 Jan; 60(1):34-46. PubMed ID: 3060545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.